Martha Rosenberg
In its 2016 to 2020 strategic plan, the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), promoted the promise of “anti-addiction vaccines “aimed at eliciting antibodies that block the effects of a specific drug.”
The quest for an anti-addiction vaccine began in earnest when Drs. Nora D. Volkow, NIDA director, and Francis S. Collins, then-NIH director, called on scientists and industry to help develop vaccines specific against opioids …
How exactly do anti-addiction vaccines work?
… the vaccine “would stimulate a person’s immune system to produce antibodies that” … “would shut down the narcotic before it could take root in the body, or in the brain …
